6505--tymlos (abaloparatide)
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C77024Q0083
- Agency
- Veterans Integrated Service Network 15 Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice was published by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15. The notice announces the agency's intent to award a sole source contract to Priority Healthcare Distributor Inc., doing business as Curascript Specialty Distribution, for the pharmaceutical Abaloparatide 80mcg/0.04ml pen.
The Special Notice restricts competition and justifies a sole source award to Curascript due to an unusual and compelling urgency. Curascript is currently the distributor for the product's manufacturer, Radius Health Inc., and has the pharmaceutical readily available. Interested parties were required to submit any notification of their ability to provide the product by January 3, 2024 to the contracting office. However, this notice is not a solicitation and the VA intends to negotiate solely with Curascript for this requirement. The statutory authority permitting restricted competition is the Simplified Procedures for Certain Commercial Items under FAR 13.5, citing 41 U.S.C 1901. Other contractors may use this notice to make the VA aware of their ability to supply the product for future requirements.
Notice text
SPECIAL NOTICE OF INTENT TO AWARD A SOLE SOURCE PROCUREMENT:
This is not a request for quote. This is a notice of the Government s intent to issue a sole source award.
This Notice is to announce that the Department of Veteran Affairs, Consolidated Mail-Out Pharmacy (CMOP) located in Tucson, AZ, is proposing to negotiate a contract with Priority Healthcare Distributor Inc. dba Curascript Specialty Distribution (Curascript), a small business on a sole source basis for the pharmaceutical Abaloparatide (NDC 70539-0001-02) 80mcg/0.04ml Pen 1.56ml.
Statutory Authority Permitting Restricted Competition:
FAR 13.5 Simplified Procedure for Certain Commercial Items. The Statutory authority for applying the Simplified Procedures for Commercial Items of FAR 13.5 is 41 U.S.C & 1901 and is implemented by FAR 13.106-1(b)(2) for restricting competition on this procurement. Competition is restricted on the procurement for the reason below:
Unusual and compelling Urgency
The Government believes the reason justifying this sole source procurement is that Curascript is a distributor of the manufacturer Radius Health Inc. and has the product available.
This is not a request for quotes and any interested party may notify the network contracting office (NCO) 15, via email to Brigitte.Kidder@va.gov to express their ability to provide these products for future needs.
Attachments
| File | Type | Posted |
|---|---|---|
| 36C77024Q0083_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--tymlos (abaloparatide) | Award Notice | |
| 6505 - pharm tymlos | Limited / Sole Source Justification | |
| 6505--tymlos (abaloparatide) | Special Notice |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity